Literature DB >> 3242524

Mumps-induced opsoclonus-myoclonus and ataxia.

N Ichiba1, Y Miyake, K Sato, M Oda, H Kimoto.   

Abstract

A 9-year-old boy manifested acute cerebellar ataxia associated with mumps infection. He developed opsoclonus, myoclonus, tremor, and truncal ataxia 7 days after mumps infection. Lumbar puncture revealed pleocytosis without elevation of protein; ELISA demonstrated an increased IgM titer of cerebrospinal fluid against mumps virus. From these results it was determined that acute cerebellar ataxia was induced by a direct invasion of mumps virus. Electroencephalography demonstrated normal background activity, although alpha-like activity appeared bilaterally in the frontal regions which was induced by eye closure and decreased by eye opening. Polygraphic electroencephalography revealed that the alpha-like activity corresponded to the ocular movement recorded above or lateral to the eyelids by electro-oculography; therefore, the alpha-like activity was considered to be derived from the opsoclonus which was secondary to cerebellar involvement. His neurologic symptoms improved gradually and resolved completely within 3 months after the onset of acute cerebellar ataxia.

Entities:  

Mesh:

Year:  1988        PMID: 3242524     DOI: 10.1016/0887-8994(88)90035-5

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

Review 1.  Myoclonus and epilepsies.

Authors:  N Fejerman
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

2.  Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain.

Authors:  S A Rubin; M Pletnikov; K M Carbone
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Complications of mumps requiring hospitalization in children.

Authors:  M Nussinovitch; B Volovitz; I Varsano
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

4.  Opsoclonus-myoclonus syndrome associated with mumps virus infection.

Authors:  Bong-Hui Kang; Jae-Il Kim
Journal:  J Clin Neurol       Date:  2014-07-03       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.